G
The startup develops pharmaceutical compounds targeting orphan and intractable diseases, specifically in psychiatry, neurology, and pulmonary arterial hypertension. By providing cost-effective treatment options, the company enables physicians to manage rare and incurable conditions more effectively.
Fujisawa, Japan
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops pharmaceutical compounds targeting orphan and intractable diseases, specifically in psychiatry, neurology, and pulmonary arterial hypertension. By providing cost-effective treatment options, the company enables physicians to manage rare and incurable conditions more effectively.